The Latest in Clinical Topics & News

MS May Have a Measurable Prodrome

May 25, 2017

Multiple Sclerosis

TNFSF13B variant linked to MS and SLE

April 26, 2017

Multiple Sclerosis

Ocrelizumab gets first-ever FDA approval for primary progressive MS

March 29, 2017

Multiple Sclerosis

Early Interferon Treatment Delays Time to Clinically Definite MS

March 6, 2017

Multiple Sclerosis

Switch From Fingolimod to Alemtuzumab Might Trigger MS Relapse

March 3, 2017

Multiple Sclerosis

Relatives of Patients With MS Show Early Signs of Disease

March 3, 2017

Multiple Sclerosis

Treatment Reduces Risk of Long-Term Disability in MS

January 27, 2017

Multiple Sclerosis

New report highlights gaps in knowledge on marijuana use

January 21, 2017

Multiple Sclerosis

Switch from fingolimod to alemtuzumab might trigger MS relapse

January 19, 2017

Multiple Sclerosis

High-risk relatives of MS patients show early signs of disease

January 17, 2017

Multiple Sclerosis

Lack of natalizumab concentration increase before PML argues against extending dosing interval

December 14, 2016

Multiple Sclerosis

Nomogram predicts conversion of first demyelinating event to definite MS

December 5, 2016

Multiple Sclerosis

Higher Latitude Is Associated With Earlier Age of MS Onset

November 28, 2016

Multiple Sclerosis

MS relapse predictors identified after patients stop treatment

November 1, 2016

Multiple Sclerosis